IMX-110 + anti-PD-1 Combination Produced Extended Median Survival in Genetic Pancreatic Cancer Mouse Model, Bolstering Planned 2022 IMX-110 Combination Clinical Trial Rationale IMX-110 + anti-PD-1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results